Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Huwiler

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Pharmacology & Therapeutics|November 12, 2017
The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectivesAndrea Huwiler, Uwe Zangemeister-Wittke
Critical Reviews in Oncology/Hematology|June 15, 2007
Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapyAndrea Huwiler, Uwe Zangemeister-Wittke
Biochimica Et Biophysica Acta|January 18, 2006
The epidermal growth factor stimulates sphingosine kinase-1 expression and activity in the human mammary carcinoma cell line MCF7Frauke Döll, Josef Pfeilschifter, Andrea Huwiler
British Journal of Pharmacology|July 24, 2010
Sphingosine kinase 1 is critically involved in nitric oxide-mediated human endothelial cell migration and tube formationStephanie Schwalm, Josef Pfeilschifter, Andrea Huwiler
Journal of the American Society of Nephrology : JASN|July 23, 2003
Nitric oxide and mechanisms of redox signalingJosef Pfeilschifter, Wolfgang Eberhardt, Andrea Huwiler
Endocrine-Related Cancer|July 20, 2007
Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migrationFrauke Döll, Josef Pfeilschifter, Andrea Huwiler
FEBS Letters|December 17, 2002
Nitric oxide induces neutral ceramidase degradation by the ubiquitin/proteasome complex in renal mesangial cell culturesRochus Franzen, Josef Pfeilschifter, Andrea Huwiler
Basic & Clinical Pharmacology & Toxicology|June 25, 2013
Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseasesStephanie Schwalm, Josef Pfeilschifter, Andrea Huwiler
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 6, 2013
Sphingosine 1-phosphate in renal diseasesAlexander Koch, Josef Pfeilschifter, Andrea Huwiler
Biochimica Et Biophysica Acta|August 15, 2012
Sphingosine-1-phosphate: a Janus-faced mediator of fibrotic diseasesStephanie Schwalm, Josef Pfeilschifter, Andrea Huwiler
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Pharmacology & Therapeutics|November 12, 2017
The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectivesAndrea Huwiler, Uwe Zangemeister-Wittke
Critical Reviews in Oncology/Hematology|June 15, 2007
Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapyAndrea Huwiler, Uwe Zangemeister-Wittke
Biochimica Et Biophysica Acta|January 18, 2006
The epidermal growth factor stimulates sphingosine kinase-1 expression and activity in the human mammary carcinoma cell line MCF7Frauke Döll, Josef Pfeilschifter, Andrea Huwiler
British Journal of Pharmacology|July 24, 2010
Sphingosine kinase 1 is critically involved in nitric oxide-mediated human endothelial cell migration and tube formationStephanie Schwalm, Josef Pfeilschifter, Andrea Huwiler
Journal of the American Society of Nephrology : JASN|July 23, 2003
Nitric oxide and mechanisms of redox signalingJosef Pfeilschifter, Wolfgang Eberhardt, Andrea Huwiler
Endocrine-Related Cancer|July 20, 2007
Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migrationFrauke Döll, Josef Pfeilschifter, Andrea Huwiler
FEBS Letters|December 17, 2002
Nitric oxide induces neutral ceramidase degradation by the ubiquitin/proteasome complex in renal mesangial cell culturesRochus Franzen, Josef Pfeilschifter, Andrea Huwiler
Basic & Clinical Pharmacology & Toxicology|June 25, 2013
Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseasesStephanie Schwalm, Josef Pfeilschifter, Andrea Huwiler
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 6, 2013
Sphingosine 1-phosphate in renal diseasesAlexander Koch, Josef Pfeilschifter, Andrea Huwiler
Biochimica Et Biophysica Acta|August 15, 2012
Sphingosine-1-phosphate: a Janus-faced mediator of fibrotic diseasesStephanie Schwalm, Josef Pfeilschifter, Andrea Huwiler
Pageof 11